Novartis is expanding its prospects in cardiometabolic disease by striking a deal to acquire Anthos Therapeutics, a company in pivotal testing with a blood clot-preventing drug that could offer ...
NEW YORK (Reuters) - A drug being developed by Bayer and Johnson & Johnson has again proven better than a standard treatment in preventing dangerous blood clots among patients undergoing orthopedic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback